Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03218176
Other study ID # GARROTS (29BRC17.0087)
Secondary ID
Status Completed
Phase N/A
First received July 10, 2017
Last updated October 31, 2017
Start date July 31, 2017
Est. completion date October 23, 2017

Study information

Verified date October 2017
Source University Hospital, Brest
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A tourniquet is used to stop abundant bleeding when simple compression is not effective. The investigators will study the vascular suffering of the tourniquets according to their location on the limb: limb (arm / thigh) or distal (forearm / leg). Vascular suffering will be evaluated by the loss of the radial doppler flux for the tourniquets placed on the upper limb and in the tibial anterior to the lower limb by the loss of the pulse oximetry pulse and the collection of the signs described by the volunteers (pain, Paresthesia, cold sensation).


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date October 23, 2017
Est. primary completion date October 23, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age greater than or equal to 18 years (major)

- Volunteer to participate in research

Exclusion Criteria:

- Age less than 18 years

- Known coagulation disorder

- Known vascular disorder

- Known neurological disorder of the limbs

- Known muscle disorders of the limbs

- Presence of an implant in one of the limbs (vascular, contraceptive ...)

- Simultaneous participation in research involving anticoagulant therapy

- History of phlebitis

- Persons of full age who are subject to legal protection (safeguard of justice, person placed in curatorship, guardianship), persons deprived of their liberty.

- Pregnant women

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Proximal single upper limb
Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry
Proximal staggered upper limb
Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry
Distal single upper limb
Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry
Distal staggered upper limb
Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry
Proximal single lower limb
Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry
Proximal staggered lower limb
Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry
Distal single lower limb
Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry
Distal staggered lower limb
Measurement of pain, pressure under tourniquet, feeling and abolition of pulse doppler and pulse oximetry

Locations

Country Name City State
France CHU de Brest Brest

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Upper limb : Assessment of Pain by Digital Evaluation (EN) after 10 min of compression The main evaluation criterion for the superior member is the assessment of the pain felt according to the location of the tourniquets at the time of laying and at 10min. For the same location of tourniquet, the pain caused by the laying of one versus two tourniquets will be compared. For proximal versus distal, comparisons will be made for 1 tourniquet and for staggered tourniquets. 10 min
Primary Lower limb : Pressure (mmHg) needed to abolish the pulse The main evaluation criterion for the inferior member is the pressure under the tourniquet, necessary to obtain an abolition of the anterior tibial pulse (measured in Doppler). By means of a balloon connected to a pressure gauge and fixed under each tourniquet, a measure of the pressure exerted (in mmHg) by the tourniquet (s) on the skin will be measured at laying. The comparison will be made for each type of pose (single vs stage) between the proximal and distal layers. 10 min
Secondary Lower limb pain The pain will be relieved according to the Digital Scale at the time of the raising of the tourniquets and at 10 minutes. For the same location of tourniquet, the pain caused by the laying of one versus two tourniquets will be compared. For proximal versus distal, comparisons will be made for 1 tourniquet and for staggered tourniquets. 10 min
Secondary Upper limb pressure under tourniquet By means of a balloon connected to a pressure gauge and fixed under each tourniquet, a measure of the pressure exerted (in mmHg) by the tourniquet (s) on the skin will be measured at laying. The comparison will be made for each type of pose (single vs staggered) between the proximal and distal layers. 10 min
Secondary Pulse oximetry Evaluation of the loss of the pulse oximetry, by a pulse oximeter placed on the finger or the toe, according to each mode of pose 10 min
Secondary Loss of arterial Doppler pulse The loss of the Doppler signal on the radial artery for the upper limbs and on the tibial anterior artery for the lower limbs will be evaluated for each type of poses to confirm arterial occlusion for each type of pose. 10 min
See also
  Status Clinical Trial Phase
Completed NCT02815670 - Reversal Dabigatran Anticoagulant Effect With Idarucizumab Phase 3
Completed NCT04588350 - Clinical Investigation Evaluating a New Autotransfusion Device in Cardiac Surgery N/A
Recruiting NCT02972385 - Pharmacogenomics of Warfarin in Hispanics and Latinos
Completed NCT02569606 - Transfusion and Coagulation Management in Trauma Patients After the Introduction of a Coagulation Algorithm
Completed NCT02554006 - Predischarge Bundle to Minimize Negative Impact on Quality of Life of Nuisance Bleedings N/A
Recruiting NCT02446730 - Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome Phase 4
Completed NCT01955720 - Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran Phase 1
Completed NCT01935427 - Comparison of Compensatory Reserve Index to Intravascular Volume Change and Stroke Volume N/A
Recruiting NCT01709786 - Non-Invasive Hemoglobin Monitoring in Patients With Hemorrhage N/A
Completed NCT01191554 - Dose-ranging Study of Tranexamic Acid in Valve Surgery N/A
Completed NCT01210417 - Trauma Heart to Arm Time N/A
Completed NCT01136590 - Multicenter, Randomized Placebo-controlled Clinical Trial to Evaluate the Effect of Perioperative Use of Tranexamic Acid on Transfusion Requirements and Surgical Bleeding in Major Spine Surgery Phase 4
Completed NCT01085006 - The Effect of Tranexamic Acid on Postpartum Hemorrhage During and After Cesarean Delivery Phase 1/Phase 2
Completed NCT00700141 - Non-Interventional Study About Treatment of Hemorrhages in Thyroid Surgery With TachoSil® N/A
Completed NCT00375466 - Tranexamic Acid, Hemorrhage and Transfusions After Combined Aortic Valve Replacement and Coronary Artery Bypass Surgery. N/A
Completed NCT00479362 - Anticoagulant Therapy During Pacemaker Implantation Phase 4
Completed NCT00147420 - RCT of Zhi Byed 11 (ZB11) Versus Misoprostol in Tibet N/A
Recruiting NCT05945680 - Tranexamic Acid in Breast Esthetic Surgery. Phase 4
Completed NCT03273322 - Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure Phase 2/Phase 3
Withdrawn NCT05672407 - The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery Phase 4